Utilizing Mechanistic Modeling to Accelerate and De-risk Drug R&D
Model-Aided Drug Invention
Applied BioMath specializes in mechanistic, mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies. We bring our expansive mathematical expertise, deep understanding of biology related to many therapeutic and disease areas, and industry experience to your specific project.
How We Are Unique
Our Modeling Approach
A rigorous fit-for-purpose model development process which quantitatively integrates knowledge about therapeutics with an understanding of its mechanism of action in the context of human disease mechanisms.
Over 100 years of cumulative industry experience spanning the entire therapeutic workflow from early research to clinical pharmacology and regulatory filings.
Our modeling process, proprietary technology, and high-performance computing allow us to conduct large-scale simulations quickly and accurately, without having to take unnecessary shortcuts on the biology or the mathematics.
The goal of this collaboration was to develop a QSP model to support translation from preclinical to clinical studies, and first-in-human (FIH) studies and to use this QSP model to provide a deeper understanding of the mechanisms of hUGT1A1-modRNA and to guide design of the first-in-human clinical studies. More detail on this case study can be found in our published article in CPT: Pharmacometrics & Systems Pharmacology.